The risk or severity of adverse effects can be increased when lidocaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when tolazoline is combined with sotalol.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when sumatriptan is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Clobetasone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when ticlopidine is combined with oxycodone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with perphenazine.


The risk or severity of adverse effects can be increased when Clobetasone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Riociguat.


The risk or severity of adverse effects can be increased when brotizolam is combined with duloxetine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with tizanidine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with alclometasone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Varenicline.


The risk or severity of adverse effects can be increased when clidinium is combined with Difenoxin.


The risk or severity of adverse effects can be increased when flurazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when zaleplon is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with ketamine.


The risk or severity of adverse effects can be increased when Butethal is combined with butalbital.


The risk or severity of adverse effects can be increased when flurazepam is combined with protriptyline.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with quetiapine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with felbamate.


The risk or severity of adverse effects can be increased when bromocriptine is combined with paramethasone.


The risk or severity of adverse effects can be increased when Prasugrel is combined with Apixaban.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with bromazepam.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when dicyclomine is combined with meperidine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Butethal.


The risk or severity of adverse effects can be increased when HEROIN is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Almotriptan is combined with olanzapine.


The risk or severity of adverse effects can be increased when trimipramine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when levorphanol is combined with lithium ion.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with clorazepate.


The risk or severity of adverse effects can be increased when Spirapril is combined with Naftifine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Etidocaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with imipramine.


The risk or severity of adverse effects can be increased when Etomidate is combined with vigabatrin.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when clozapine is combined with tetracaine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Eprosartan.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with ibuprofen.


The risk or severity of adverse effects can be increased when etizolam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when procaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when dyclonine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Linagliptin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when amobarbital is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when procaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when zopiclone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with baclofen.


The risk or severity of adverse effects can be increased when phentolamine is combined with propofol.


The risk or severity of adverse effects can be increased when triazolam is combined with butalbital.


The risk or severity of adverse effects can be increased when haloperidol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with furosemide.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when ramipril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when diflorasone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with clidinium.


The risk or severity of adverse effects can be increased when pramipexole is combined with indapamide.


The risk or severity of adverse effects can be increased when Limaprost is combined with Prasugrel.


The risk or severity of adverse effects can be increased when metaproterenol is combined with benzphetamine.


The risk or severity of adverse effects can be increased when metaproterenol is combined with ritodrine.


The risk or severity of adverse effects can be increased when butenafine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with pargyline.


The risk or severity of adverse effects can be increased when triprolidine is combined with nefazodone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with thiothixene.


The risk or severity of adverse effects can be increased when tiagabine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when triprolidine is combined with doxepin.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Mometasone.


The risk or severity of adverse effects can be increased when nabumetone is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when codeine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when codeine is combined with triazolam.


The risk or severity of adverse effects can be increased when codeine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when pentazocine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when benztropine is combined with ATROPINE.


The risk or severity of adverse effects can be increased when Propacetamol is combined with medrysone.


The risk or severity of adverse effects can be increased when nimesulide is combined with loteprednol.


The risk or severity of adverse effects can be increased when benzphetamine is combined with nylidrin.


The risk or severity of adverse effects can be increased when olanzapine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when butenafine is combined with eperisone.


The risk or severity of adverse effects can be increased when ropinirole is combined with enalapril.


The risk or severity of adverse effects can be increased when dibucaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when equilin is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when triamterene is combined with penbutolol.


The risk or severity of adverse effects can be increased when Nabilone is combined with terazosin.


The risk or severity of adverse effects can be increased when clozapine is combined with Butethal.


The risk or severity of adverse effects can be increased when miconazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when amisulpride is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with trimipramine.


The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when norepinephrine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Melatonin.


The risk or severity of adverse effects can be increased when amiodarone is combined with prazosin.


The risk or severity of adverse effects can be increased when labetalol is combined with dopamine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with clonazepam.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with promethazine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with tolterodine.


The risk or severity of adverse effects can be increased when propofol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when procarbazine is combined with dobutamine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when diflunisal is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when pimozide is combined with HEROIN.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with tiapride.


The risk or severity of adverse effects can be increased when tolterodine is combined with Tramadol.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with flunisolide.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when thiamylal is combined with Escitalopram.


The risk or severity of adverse effects can be increased when cyclothiazide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when thiamylal is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when thiamylal is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Asenapine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when propofol is combined with oxymorphone.


The risk or severity of adverse effects can be increased when triazolam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when propofol is combined with captopril.


The risk or severity of adverse effects can be increased when diflunisal is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when methazolamide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when bifonazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when loxapine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when quetiapine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with tizanidine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with cetirizine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with protriptyline.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with desoximetasone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with scopolamine.


The risk or severity of adverse effects can be increased when Apremilast is combined with acemetacin.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when meclizine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when amisulpride is combined with butalbital.


The risk or severity of adverse effects can be increased when ATROPINE is combined with butorphanol.


The risk or severity of adverse effects can be increased when loxapine is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when dibucaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with metoprolol.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with flumethasone.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with tolterodine.


The risk or severity of adverse effects can be increased when Apremilast is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when primidone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Normethadone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with ambenonium.


The risk or severity of adverse effects can be increased when Normethadone is combined with pargyline.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with SULFALENE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with clonidine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sumatriptan.


The risk or severity of adverse effects can be increased when Difenoxin is combined with duloxetine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Difenoxin is combined with fluoxetine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when mitomycin C is combined with leflunomide.


The risk or severity of adverse effects can be increased when benzocaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with oxazepam.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with nalbuphine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when benzocaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when ketorolac is combined with alclofenac.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with indapamide.


The risk or severity of adverse effects can be increased when baclofen is combined with meclizine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with ondansetron.


The risk or severity of adverse effects can be increased when Asenapine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with carprofen.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when fenbufen is combined with Clobetasone.


The risk or severity of adverse effects can be increased when acemetacin is combined with budesonide.


The risk or severity of adverse effects can be increased when risperidone is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when secobarbital is combined with enflurane.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Pipamperone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with sulindac.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with tiapride.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with chloroquine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with nefazodone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with formestane.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Tramadol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ondansetron is combined with methylphenidate.


The risk or severity of adverse effects can be increased when ondansetron is combined with methocarbamol.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when ondansetron is combined with triprolidine.


The risk or severity of adverse effects can be increased when benzocaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when diclofenac is combined with suprofen.


The risk or severity of adverse effects can be increased when diclofenac is combined with loteprednol.


The risk or severity of adverse effects can be increased when benzocaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with physostigmine.


The risk or severity of adverse effects can be increased when chloroquine is combined with triamcinolone.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with dantrolene.


The risk or severity of adverse effects can be increased when procaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Nebivolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when zaleplon is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with trazodone.


The risk or severity of adverse effects can be increased when prilocaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with flunarizine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with norfloxacin.


The risk or severity of adverse effects can be increased when methazolamide is combined with nadolol.


The risk or severity of adverse effects can be increased when amisulpride is combined with maprotiline.


The risk or severity of adverse effects can be increased when miconazole is combined with felodipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with ketamine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Deferasirox.


The risk or severity of adverse effects can be increased when apraclonidine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when phenytoin is combined with amoxapine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with quetiapine.


The risk or severity of adverse effects can be increased when tretinoin is combined with sotalol.


The risk or severity of adverse effects can be increased when temazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when lidocaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when tretinoin is combined with brimonidine.


The risk or severity of adverse effects can be increased when loxapine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when morphine is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when carbamazepine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when metaraminol is combined with celiprolol.


The risk or severity of adverse effects can be increased when Sacubitril is combined with felodipine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with furosemide.


The risk or severity of adverse effects can be increased when Sacubitril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when norepinephrine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when diltiazem is combined with spironolactone.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when flumazenil is combined with clozapine.


The risk or severity of adverse effects can be increased when temazepam is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when vigabatrin is combined with paroxetine.


The risk or severity of adverse effects can be increased when penbutolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when doxepin is combined with desipramine.


The risk or severity of adverse effects can be increased when dyphylline is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when secobarbital is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when ketorolac is combined with azelastine.


The risk or severity of adverse effects can be increased when Tramadol is combined with felbamate.


The risk or severity of adverse effects can be increased when dicyclomine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with meclizine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with trandolapril.


The risk or severity of adverse effects can be increased when trimipramine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when etodolac is combined with fluocinonide.


The risk or severity of adverse effects can be increased when sumatriptan is combined with moclobemide.


The risk or severity of adverse effects can be increased when temazepam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Escitalopram.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Halobetasol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Trospium is combined with HEROIN.


The risk or severity of adverse effects can be increased when nitrazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when epirizole is combined with triamcinolone.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when lomustine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when chlormezanone is combined with butamben.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Torasemide.


The risk or severity of adverse effects can be increased when Atazanavir is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when ethopropazine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Tolcapone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when morphine is combined with propofol.


The risk or severity of adverse effects can be increased when morphine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when glutethimide is combined with primidone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with amcinonide.


The risk or severity of adverse effects can be increased when pergolide is combined with buprenorphine.


The risk or severity of adverse effects can be increased when tolmetin is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with amcinonide.


The risk or severity of adverse effects can be increased when tolmetin is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when procarbazine is combined with lithium ion.


The risk or severity of adverse effects can be increased when Almotriptan is combined with doxepin.


The risk or severity of adverse effects can be increased when betaxolol is combined with nimodipine.


The risk or severity of adverse effects can be increased when Articaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Bivalirudin is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Articaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Naftifine is combined with azelastine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with digitoxin.


The risk or severity of adverse effects can be increased when gabapentin is combined with amoxapine.


The risk or severity of adverse effects can be increased when gabapentin is combined with nortriptyline.


The risk or severity of adverse effects can be increased when antipyrine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when selegiline is combined with haloperidol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Perospirone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when selegiline is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when tretinoin is combined with penbutolol.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when pergolide is combined with daunorubicin.


The risk or severity of adverse effects can be increased when glutethimide is combined with butalbital.


The risk or severity of adverse effects can be increased when Sacubitril is combined with timolol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with methyldopa.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with oxazepam.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with IMIQUIMOD.


The risk or severity of adverse effects can be increased when nalbuphine is combined with halothane.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with topiramate.


The risk or severity of adverse effects can be increased when olanzapine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with loratadine.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with nalbuphine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Telmisartan is combined with ketoprofen.


The risk or severity of adverse effects can be increased when nitrazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with selegiline.


The risk or severity of adverse effects can be increased when clozapine is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with amoxapine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with paramethasone.


The risk or severity of adverse effects can be increased when propofol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when quazepam is combined with HEROIN.


The risk or severity of adverse effects can be increased when estazolam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when propranolol is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when budesonide is combined with tubocurarine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with resveratrol.


The risk or severity of adverse effects can be increased when propranolol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when halothane is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with codeine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when docetaxel is combined with Pirlindole.


The risk or severity of adverse effects can be increased when bifonazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with mianserin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with citalopram.


The risk or severity of adverse effects can be increased when Retigabine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when tenoxicam is combined with tolmetin.


The risk or severity of adverse effects can be increased when Apremilast is combined with desoximetasone.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with flunarizine.


The risk or severity of adverse effects can be increased when reserpine is combined with triamterene.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when estazolam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when etodolac is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with ramipril.


The risk or severity of adverse effects can be increased when dantrolene is combined with Retigabine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with amcinonide.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Halazepam.


The risk or severity of adverse effects can be increased when sulconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with carisoprodol.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with proparacaine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Pizotifen.


The risk or severity of adverse effects can be increased when amisulpride is combined with butamben.


The risk or severity of adverse effects can be increased when Carbetocin is combined with betaxolol.


The risk or severity of adverse effects can be increased when nadolol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with trimipramine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tofacitinib.


The risk or severity of adverse effects can be increased when Artemether is combined with nilvadipine.


The risk or severity of adverse effects can be increased when betamethasone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with testolactone.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when duloxetine is combined with maprotiline.


The risk or severity of adverse effects can be increased when thioguanine is combined with clozapine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when methylphenidate is combined with Rotigotine.


The risk or severity of adverse effects can be increased when barnidipine is combined with fenoldopam.


The risk or severity of adverse effects can be increased when spironolactone is combined with AMMONIUM CHLORIDE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with efavirenz.


The risk or severity of adverse effects can be increased when propofol is combined with estazolam.


The risk or severity of adverse effects can be increased when barnidipine is combined with indapamide.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when propoxyphene is combined with metolazone.


The risk or severity of adverse effects can be increased when reserpine is combined with metolazone.


The risk or severity of adverse effects can be increased when pancuronium is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when reserpine is combined with dibucaine.


The risk or severity of adverse effects can be increased when brimonidine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when estazolam is combined with Articaine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with clomipramine.


The risk or severity of adverse effects can be increased when perphenazine is combined with quetiapine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with scopolamine.


The risk or severity of adverse effects can be increased when perphenazine is combined with ketamine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when gabapentin is combined with nitrazepam.


The risk or severity of adverse effects can be increased when meprobamate is combined with Perospirone.


The risk or severity of adverse effects can be increased when antipyrine is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with codeine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when suprofen is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with nimesulide.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when tretinoin is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when nabumetone is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when thioridazine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when nabumetone is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when methysergide is combined with tacrolimus.


The risk or severity of adverse effects can be increased when thioridazine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Flupentixol.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Phenelzine.


The risk or severity of adverse effects can be increased when levorphanol is combined with butalbital.


The risk or severity of adverse effects can be increased when amobarbital is combined with triflupromazine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Isavuconazole is combined with simvastatin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with acetazolamide.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when bupivacaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with oxaprozin.


The risk or severity of adverse effects can be increased when doxycycline is combined with atorvastatin.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Asenapine is combined with flunarizine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Fospropofol.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Treprostinil is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with thioridazine.


The risk or severity of adverse effects can be increased when nabumetone is combined with medrysone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with metolazone.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with lomustine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when citalopram is combined with amisulpride.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with selegiline.


The risk or severity of adverse effects can be increased when fenoprofen is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when salicylic acid is combined with flunisolide.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with thalidomide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with tiapride.


The risk or severity of adverse effects can be increased when alprazolam is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Retigabine.


The risk or severity of adverse effects can be increased when practolol is combined with nicotine.


The risk or severity of adverse effects can be increased when propofol is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when alprazolam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with mefloquine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with alclofenac.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when buspirone is combined with loratadine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with flunarizine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with thioridazine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with equilin.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when thiopental is combined with Retigabine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when suprofen is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with cilazapril.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Lofexidine.


The risk or severity of adverse effects can be increased when furazolidone is combined with bezafibrate.


The risk or severity of adverse effects can be increased when thiopental is combined with butalbital.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with Spirapril.


The risk or severity of adverse effects can be increased when gabapentin is combined with glutethimide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with epoprostenol.


The risk or severity of adverse effects can be increased when doxepin is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with loteprednol.


The risk or severity of adverse effects can be increased when levorphanol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with suprofen.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with diclofenac.


The risk or severity of adverse effects can be increased when Spirapril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when budesonide is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when resveratrol is combined with epirizole.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Pipamperone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Dothiepin is combined with celiprolol.


The risk or severity of adverse effects can be increased when ketoprofen is combined with fenbufen.


The risk or severity of adverse effects can be increased when lisinopril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when amobarbital is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Olopatadine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with nadolol.


The risk or severity of adverse effects can be increased when thalidomide is combined with atenolol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when trazodone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when trazodone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when reserpine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Olmesartan is combined with methyldopa.


The risk or severity of adverse effects can be increased when clozapine is combined with epoprostenol.


The risk or severity of adverse effects can be increased when etizolam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when methoxamine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when rasagiline is combined with sotalol.


The risk or severity of adverse effects can be increased when rasagiline is combined with brimonidine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when codeine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with tubocurarine.


The risk or severity of adverse effects can be increased when zonisamide is combined with maprotiline.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when thioridazine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with felbamate.


The risk or severity of adverse effects can be increased when thioridazine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when tiapride is combined with protriptyline.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with paramethasone.


The risk or severity of adverse effects can be increased when thioridazine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when pimozide is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with glutethimide.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when cocaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when estazolam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when celecoxib is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Rufinamide is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Telmisartan.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when sildenafil is combined with Flibanserin.


The risk or severity of adverse effects can be increased when HEROIN is combined with primidone.


The risk or severity of adverse effects can be increased when thiopental is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when haloperidol is combined with Asenapine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when metoprolol is combined with metolazone.


The risk or severity of adverse effects can be increased when triamterene is combined with papaverine.


The risk or severity of adverse effects can be increased when imipramine is combined with triamterene.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with clomipramine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with methazolamide.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with budesonide.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with desoximetasone.


The risk or severity of adverse effects can be increased when carprofen is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when ILOPROST is combined with sevoflurane.


The risk or severity of adverse effects can be increased when halothane is combined with oxprenolol.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with halcinonide.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with difluprednate.


The risk or severity of adverse effects can be increased when Linagliptin is combined with captopril.


The risk or severity of adverse effects can be increased when zaleplon is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when sotalol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with resveratrol.


The risk or severity of adverse effects can be increased when tiagabine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when zonisamide is combined with vigabatrin.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when irbesartan is combined with Nebivolol.


The risk or severity of adverse effects can be increased when halothane is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when olanzapine is combined with thiothixene.


The risk or severity of adverse effects can be increased when Perospirone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when olanzapine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when THYMOL is combined with Benidipine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when perphenazine is combined with Halazepam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with quetiapine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with methscopolamine.


The risk or severity of adverse effects can be increased when Asenapine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when amitriptyline is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when procarbazine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when procarbazine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with cinoxacin.


The risk or severity of adverse effects can be increased when procarbazine is combined with thiothixene.


The risk or severity of adverse effects can be increased when cabergoline is combined with ranitidine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with trapidil.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Masoprocol.


The risk or severity of adverse effects can be increased when cabergoline is combined with tacrolimus.


The risk or severity of adverse effects can be increased when brotizolam is combined with clidinium.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with fludiazepam.


The risk or severity of adverse effects can be increased when oxycodone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Remoxipride.


The risk or severity of adverse effects can be increased when butorphanol is combined with Torasemide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with amisulpride.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Ruxolitinib.


The risk or severity of adverse effects can be increased when lisinopril is combined with floctafenine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when dapsone is combined with lidocaine.


The risk or severity of adverse effects can be increased when imipramine is combined with selegiline.


The risk or severity of adverse effects can be increased when carvedilol is combined with Riociguat.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when protriptyline is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when protriptyline is combined with ethotoin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with dibucaine.


The risk or severity of adverse effects can be increased when cabergoline is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when azelastine is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when flumethasone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when meperidine is combined with Mersalyl.


The risk or severity of adverse effects can be increased when metoclopramide is combined with haloperidol.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with tolterodine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when felodipine is combined with Riociguat.


The risk or severity of adverse effects can be increased when triprolidine is combined with clidinium.


The risk or severity of adverse effects can be increased when Etomidate is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with labetalol.


The risk or severity of adverse effects can be increased when amcinonide is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when epoprostenol is combined with imipramine.


The risk or severity of adverse effects can be increased when enalapril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with bumetanide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Paliperidone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with clomiphene.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with quinapril.


The risk or severity of adverse effects can be increased when etodolac is combined with salicylic acid.


The risk or severity of adverse effects can be increased when resveratrol is combined with estrone.


The risk or severity of adverse effects can be increased when lorazepam is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with isradipine.


The risk or severity of adverse effects can be increased when bepridil is combined with apraclonidine.


The risk or severity of adverse effects can be increased when fosinopril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with amitriptyline.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Tolcapone.


The risk or severity of adverse effects can be increased when ondansetron is combined with tiapride.


The risk or severity of adverse effects can be increased when valsartan is combined with sulindac.


The risk or severity of adverse effects can be increased when valsartan is combined with chloroquine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with medrysone.


The risk or severity of adverse effects can be increased when meprobamate is combined with Flibanserin.


The risk or severity of adverse effects can be increased when baclofen is combined with promethazine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Tianeptine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when zopiclone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when oxiconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when amoxapine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with etoposide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with mesalamine.


The risk or severity of adverse effects can be increased when lidocaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when zopiclone is combined with glutethimide.


The risk or severity of adverse effects can be increased when sulindac is combined with fenbufen.


The risk or severity of adverse effects can be increased when ramipril is combined with mecamylamine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pemetrexed.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with diazepam.


The risk or severity of adverse effects can be increased when Pramocaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with edrophonium.


The risk or severity of adverse effects can be increased when secobarbital is combined with isoflurane.


The risk or severity of adverse effects can be increased when methylergonovine is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when Pramocaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when methylergonovine is combined with clotrimazole.


The risk or severity of adverse effects can be increased when zaleplon is combined with cetirizine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with tiapride.


The risk or severity of adverse effects can be increased when Alogliptin is combined with rescinnamine.


The risk or severity of adverse effects can be increased when zaleplon is combined with protriptyline.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Halazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with cilazapril.


The risk or severity of adverse effects can be increased when proparacaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when flurazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when proparacaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Micafungin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with butorphanol.


The risk or severity of adverse effects can be increased when Olsalazine is combined with equilin.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with medrysone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with trimipramine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with clonidine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with losartan.


The risk or severity of adverse effects can be increased when proparacaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with propranolol.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with estrone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with procaine.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with memantine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with zaleplon.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when griseofulvin is combined with gabapentin.


The risk or severity of adverse effects can be increased when betaxolol is combined with mecamylamine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with scopolamine.


The risk or severity of adverse effects can be increased when methenamine is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when promazine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with mepivacaine.


The risk or severity of adverse effects can be increased when procaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when morphine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when methadone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when perphenazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when acetaminophen is combined with prilocaine.


The risk or severity of adverse effects can be increased when carprofen is combined with suprofen.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when prazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when clomipramine is combined with triamterene.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when ILOPROST is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when spironolactone is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when quetiapine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Retigabine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with ethotoin.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with amcinonide.


The risk or severity of adverse effects can be increased when Conivaptan is combined with captopril.


The risk or severity of adverse effects can be increased when Butethal is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with acebutolol.


The risk or severity of adverse effects can be increased when levorphanol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Sunitinib.


The risk or severity of adverse effects can be increased when Isavuconazonium is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when Torasemide is combined with cilazapril.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with carvedilol.


The risk or severity of adverse effects can be increased when clonazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when tiapride is combined with clonidine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Apremilast.


The risk or severity of adverse effects can be increased when tetracaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with topotecan.


The risk or severity of adverse effects can be increased when celecoxib is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Bretylium.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with baclofen.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with HEROIN.


The risk or severity of adverse effects can be increased when nicardipine is combined with terazosin.


The risk or severity of adverse effects can be increased when losartan is combined with methazolamide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when ILOPROST is combined with bumetanide.


The risk or severity of adverse effects can be increased when pentamidine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when pentamidine is combined with foscarnet.


The risk or severity of adverse effects can be increased when floctafenine is combined with equilin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ketamine.


The risk or severity of adverse effects can be increased when metoprolol is combined with nisoldipine.


The risk or severity of adverse effects can be increased when ketamine is combined with doxepin.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with thioridazine.


The risk or severity of adverse effects can be increased when prilocaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when citalopram is combined with meperidine.


The risk or severity of adverse effects can be increased when losartan is combined with Olsalazine.


The risk or severity of adverse effects can be increased when betaxolol is combined with indapamide.


The risk or severity of adverse effects can be increased when metoprolol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when cabergoline is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Etomidate is combined with dibucaine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with linezolid.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with nefazodone.


The risk or severity of adverse effects can be increased when rapamycin is combined with Amrinone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with loratadine.


The risk or severity of adverse effects can be increased when ramipril is combined with acebutolol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Capsaicin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Fospropofol.


The risk or severity of adverse effects can be increased when estazolam is combined with enflurane.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when ketamine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when ramipril is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with prazepam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with quazepam.


The risk or severity of adverse effects can be increased when metoprolol is combined with methyldopa.


The risk or severity of adverse effects can be increased when dyclonine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when propofol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Naftifine is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with oxprenolol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when meperidine is combined with Retigabine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when brimonidine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when spironolactone is combined with quetiapine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with felodipine.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when diazepam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when bromocriptine is combined with irbesartan.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Rufinamide is combined with flunarizine.


The risk or severity of adverse effects can be increased when pramipexole is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when hydromorphone is combined with topiramate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with meperidine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with loratadine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Nepafenac.


The risk or severity of adverse effects can be increased when tiapride is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Aclidinium is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with dexamethasone.


The risk or severity of adverse effects can be increased when pancuronium is combined with Metixene.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when PROCATEROL is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when estazolam is combined with thiopental.


The risk or severity of adverse effects can be increased when Caspofungin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when propofol is combined with furosemide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when propofol is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ethosuximide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with doxazosin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Articaine.


The risk or severity of adverse effects can be increased when resveratrol is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with thiopental.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with morphine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with xylometazoline.


The risk or severity of adverse effects can be increased when zotepine is combined with tiapride.


The risk or severity of adverse effects can be increased when lidocaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with acetazolamide.


The risk or severity of adverse effects can be increased when baclofen is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when mesoridazine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when bepridil is combined with clonidine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when bepridil is combined with propranolol.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with droperidol.


The risk or severity of adverse effects can be increased when ketamine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Pazopanib is combined with leflunomide.


The risk or severity of adverse effects can be increased when risperidone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with equilin.


The risk or severity of adverse effects can be increased when THYMOL is combined with Efonidipine.


The risk or severity of adverse effects can be increased when alclometasone is combined with enoxacin.


The risk or severity of adverse effects can be increased when mecamylamine is combined with HEROIN.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when ketorolac is combined with indomethacin.


The risk or severity of adverse effects can be increased when estazolam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when estazolam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when formestane is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when hydromorphone is combined with indapamide.


The risk or severity of adverse effects can be increased when Caspofungin is combined with isradipine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Melatonin.


The risk or severity of adverse effects can be increased when estazolam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when prilocaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Icatibant is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when cocaine is combined with butalbital.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with equilin.


The risk or severity of adverse effects can be increased when ondansetron is combined with prazepam.


The risk or severity of adverse effects can be increased when oxycodone is combined with enflurane.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ondansetron is combined with oxprenolol.


The risk or severity of adverse effects can be increased when rizatriptan is combined with promethazine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Halazepam.


The risk or severity of adverse effects can be increased when ipratropium is combined with propoxyphene.


The risk or severity of adverse effects can be increased when halothane is combined with enalapril.


The risk or severity of adverse effects can be increased when proparacaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with triprolidine.


The risk or severity of adverse effects can be increased when halothane is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when quetiapine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with ethotoin.


The risk or severity of adverse effects can be increased when proparacaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Tapentadol.


The risk or severity of adverse effects can be increased when dyclonine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with flunisolide.


The risk or severity of adverse effects can be increased when risperidone is combined with triprolidine.


The risk or severity of adverse effects can be increased when Etomidate is combined with brotizolam.


The risk or severity of adverse effects can be increased when risperidone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when risperidone is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with prilocaine.


The risk or severity of adverse effects can be increased when clomipramine is combined with fenoldopam.


The risk or severity of adverse effects can be increased when oxprenolol is combined with bumetanide.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with papaverine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when ondansetron is combined with Ramelteon.


The risk or severity of adverse effects can be increased when clomipramine is combined with indapamide.


The risk or severity of adverse effects can be increased when cabergoline is combined with losartan.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with diazoxide.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with flunarizine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Riociguat.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Toloxatone is combined with moclobemide.


The risk or severity of adverse effects can be increased when dibucaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when duloxetine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Pinaverium.


The risk or severity of adverse effects can be increased when etodolac is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with zonisamide.


The risk or severity of adverse effects can be increased when benazepril is combined with cilazapril.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with protriptyline.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when etodolac is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with cetirizine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when ketorolac is combined with ibuprofen.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Asenapine.


The risk or severity of adverse effects can be increased when proparacaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with clomipramine.


The risk or severity of adverse effects can be increased when proparacaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with clidinium.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with tiapride.


The risk or severity of adverse effects can be increased when Bortezomib is combined with spironolactone.


The risk or severity of adverse effects can be increased when gabapentin is combined with Tolcapone.


The risk or severity of adverse effects can be increased when gabapentin is combined with amitriptyline.


The risk or severity of adverse effects can be increased when diclofenac is combined with celecoxib.


The risk or severity of adverse effects can be increased when apomorphine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when cabergoline is combined with quetiapine.


The risk or severity of adverse effects can be increased when zopiclone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when zopiclone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when acemetacin is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with meclizine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with isradipine.


The risk or severity of adverse effects can be increased when formestane is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with deslanoside.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Olmesartan.


The risk or severity of adverse effects can be increased when zopiclone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when formestane is combined with malathion.


The risk or severity of adverse effects can be increased when vincristine is combined with leflunomide.


The risk or severity of adverse effects can be increased when fosinopril is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when propantheline is combined with Pentolinium.


The risk or severity of adverse effects can be increased when sulconazole is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Aliskiren.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when Vecuronium is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when pimozide is combined with chlormezanone.


The risk or severity of adverse effects can be increased when spironolactone is combined with Aliskiren.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when pergolide is combined with Lurasidone.


The risk or severity of adverse effects can be increased when prilocaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with ethotoin.


The risk or severity of adverse effects can be increased when phenylephrine is combined with isoxsuprine.